Immunis Named Among Top 25 Biotech & Life Sciences Companies for 2025 by The Healthcare Technology Report
Immunis, Inc., a clinical-stage biotech pioneering multi-active stem cell-derived biologics for age and disease-related immune dysregulation, was honored as one of the “Top 25 Biotech & Life Sciences Companies for 2025” by The Healthcare Technology Report. This award is highly regarded by corporate executives, ins…
